Hemorheology and Haemostasis Unit, Service of Clinical Pathology, La Fe University Hospital, Valencia, Spain.
Clin Hemorheol Microcirc. 2011;48(4):247-55. doi: 10.3233/CH-2011-1417.
There are few studies on haemorheological disturbances in morbidly obese patients. The role played by the metabolic syndrome on the rheological profile of morbidly obese subjects has not yet been established, and it is not clear whether morbidly obese, but "metabolically healthy", show rheological alterations. We aimed to determine the whole rheological profile in 136 morbidly obese patients and 136 normo-weight volunteers, along with plasma lipids, inflammatory and insulin resistance parameters. Patients had statistically higher glucose, triglycerides, HbA1c, leptin, insulin, HOMA, CRP, leucocytes, fibrinogen, plasma viscosity (p < 0.001, respectively), erythrocyte aggregation at 3 s-1 (p = 0.011) and lower erythrocyte elongation index 60 Pa (p = 0.015). In the multivariate regression analysis, the anthropometric, lipidic, insulin resistance and inflammatory parameters predicted haemorheological variables (p < 0.001). No differences were observed for the rheological parameters when morbidly obese subjects with (n = 75) and without (n = 61) the metabolic syndrome were compared (p > 0.05), indicating that the altered rheological profile not only related to the metabolic syndrome, but to obesity itself. When further patients were classified as "metabolically healthy" obese (n = 23) and "metabolically unhealthy" obese (n = 113), the latter presented higher insulin resistance (insulin p < 0.01, HOMA p < 0.05, glucose p < 0.001, triglycerides p < 0.05 and HbA1c p < 0.01) than the former, but no differences in the rheological parameters (p > 0.05) were observed. When "metabolically healthy" obese (n = 23) were compared with "metabolically healthy" controls (n = 81), the former still showed higher HOMA (p < 0.001), triglycerides (p < 0.05), CRP (p < 0.001) and HbA1c (p < 0.05), higher fibrinogen (p < 0.001), plasma viscosity (p < 0.001), erythrocyte aggregation at 3 s-1 (p < 0.05), but a lower erythrocyte elongation index 60 Pa (p < 0.05). Morbidly obese subjects present a more pronounced altered rheological profile in those with metabolic alterations, although the "metabolically healthy" obese also displayed rheological alterations if compared with "metabolically healthy" non-obese controls. These rheological alterations relate to both insulin resistance and inflammation.
关于病态肥胖患者血液流变学紊乱的研究甚少。代谢综合征对病态肥胖患者流变特性的影响尚未确定,也不清楚病态肥胖但“代谢健康”的患者是否存在流变学改变。我们旨在确定 136 例病态肥胖患者和 136 例体重正常志愿者的全血流变学特征,以及血浆脂质、炎症和胰岛素抵抗参数。与体重正常志愿者相比,患者的血糖、甘油三酯、HbA1c、瘦素、胰岛素、HOMA、CRP、白细胞、纤维蛋白原和血浆黏度更高(p<0.001),红细胞在 3 s-1 时的聚集率更高(p=0.011),红细胞 60 Pa 时的延伸指数更低(p=0.015)。在多元回归分析中,体重指数、血脂、胰岛素抵抗和炎症参数预测血液流变学变量(p<0.001)。比较有代谢综合征的病态肥胖患者(n=75)和无代谢综合征的病态肥胖患者(n=61)时,血液流变学参数无差异(p>0.05),表明改变的流变学特征不仅与代谢综合征有关,还与肥胖本身有关。当进一步将患者分为“代谢健康”肥胖(n=23)和“代谢不健康”肥胖(n=113)时,后者的胰岛素抵抗更高(胰岛素 p<0.01,HOMA p<0.05,血糖 p<0.001,甘油三酯 p<0.05,HbA1c p<0.01),但血液流变学参数无差异(p>0.05)。与“代谢健康”肥胖(n=23)相比,“代谢健康”对照组(n=81)仍表现出更高的 HOMA(p<0.001)、甘油三酯(p<0.05)、CRP(p<0.001)和 HbA1c(p<0.05)、更高的纤维蛋白原(p<0.001)、血浆黏度(p<0.001)、红细胞在 3 s-1 时的聚集率(p<0.05),但红细胞 60 Pa 时的延伸指数更低(p<0.05)。病态肥胖患者的血液流变学特征明显改变,尤其是在存在代谢改变的情况下,但与“代谢健康”非肥胖对照组相比,“代谢健康”肥胖患者也存在血液流变学改变。这些流变学改变与胰岛素抵抗和炎症有关。